Recognizing exacerbations of COPD and managing underlying inflammation
This infographic provides an overview of how to recognize and manage exacerbations in patients with COPD and the overall impact of these exacerbations on patient care, along with insights from Dr. Nicola A. Hanania. Comorbidities associated with type 2 and neutrophilic inflammation are also outlined.
Developed by:
Springer Healthcare
Log in to access the infographic
With insights from Dr. Nicola A. Hanania, this infographic aims to broaden the understanding of COPD exacerbations in order to optimize patient care in day-to-day clinical practice.
The infographic outlines:
- how to identify and classify exacerbations
- the increasing incidence with age
- the impact on the patient and the system
- the cellular players and repercussions of neutrophilic and type 2 inflammation
- management strategies at the physician- and patient-level
Dr. Nicola A. Hanania
Nicola (Nick) A. Hanania is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas, USA.
Read more »
Springer Healthcare
Springer Healthcare carried out a literature review on recent publications on the management of COPD exacerbations, then created and edited the infographic after liaising with a Pulmonary and Critical Care Physician, Dr. Nicola A. Hanania.
Dr. Nicola A. Hanania provided some relevant resources and PowerPoint slides of his presentations that informed the topics that were ultimately included, as well as reviewing and approving the infographic at all stages.
Financial disclosure
This educational program is financially supported by Sanofi and Regeneron. The content and faculty for this program have been independently developed and/or selected by Springer Healthcare.
Disclaimer
Any information provided and opinions expressed do not necessarily reflect the views of Springer Medizin GmbH. Springer Medizin GmbH and its employees, agents and subcontractors are not responsible or in any way liable for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising therefrom. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Please consult the latest prescribing information from the manufacturer before issuing prescriptions for any products mentioned.
